Canadian brand spotlight series: Get to know Well.ca
Welcome back to our Canadian brand spotlight series! This time, we're shining a light on Well.ca, a trusted homegrown destination for wellness, beauty and everyday essentials.
Founded in 2008, Well.ca has grown into a go-to online hub for Canadians looking to shop consciously, offering a curated selection of products that support health, sustainability, and quality living. Known for its thoughtful mix of trusted brands and innovative finds, Well.ca makes it easy to care for yourself and your home without compromise.
Whether you're refreshing your self-care routine, upgrading your kitchen tools, or discovering new wellness must-haves, Well.ca has something for every lifestyle and budget. Ahead, we're sharing a few of our favourite picks from their vast collection of beauty, home and wellness essentials.
Story continues below advertisement
Three Ships Hydrating + Firming Serum Duo Bundle
Glow up your skincare routine with the Three Ships 3-Ship Bundle – two award-winning, Canadian-made serums that hydrate, brighten, and smooth your skin effortlessly, all while keeping it cruelty-free and clean! Perfect for a little self-care boost or a thoughtful gift for the skincare lover in your life. $90.00 at Well.ca
Nudestix Roses N' Honey Nudes
Don't sleep on the makeup sets from Well.ca – they're the easiest way to get a fresh, glowing look in minutes. With these mini Nudies for eyes, cheeks, and lips, golden-hour glow is basically guaranteed. $39.00 at Well.ca
Milk Jar Candle Co. Wooden Wick Candle Bohemia
This candle captures that spontaneous vibe of roadside adventures – fresh lemongrass, soothing lavender, and earthy sage, minus the van chaos. Perfect for bringing a little BC magic (and serenity) into your home. $38.99 at well.ca
Story continues below advertisement
Jan & Jul Kids Backpack & Lunch Bag Macarons Bundle
Treat your little ones to this super cute Jan & Jul bundle, now at well.ca! The Little Xplorers backpack and matching lunch bag in playful macaron shades make school days – and every adventure after – both fun and organized. $60.31 at well.ca
Good Protein All-in-One Shake Mocha
Good Protein's Mocha All-in-One Shake, now available at well.ca, blends bold coffee flavour with a hint of chocolate for a delicious, on-the-go protein boost. $37.97 at well.ca
AOR Saffron 2.0
AOR Saffron 2.0 uses a special saffron extract that can help ease stress, lift your mood, and support better sleep – making it a natural way for teens and adults to feel more relaxed and balanced. $53.49 at well.ca
Story continues below advertisement
YETI Rambler Chug Bottle Black Forest Green
The YETI Rambler insulated water bottle – built tough for commutes, hikes, and kayak trips – is designed to keep drinks at the perfect temperature sip after sip, and yes, you can snag YETI products like this one right on well.ca! $42.00 at well.ca
Mrs. Meyer's Clean Day Apple Cider Bundle
Bring eco-friendly freshness to your home this fall with the Mrs. Meyer's Apple Cider Bundle – packed with hand soap, dish soap, and multi-surface cleaner that are gentle on your hands, tough on messes, and scented with crisp, orchard-fresh Apple Cider. Perfect for adding a seasonal touch while keeping your cleaning routine sustainable and cruelty-free. $16.27 at well.ca
You may also like:
ILIA Soft Focus Blurring Blush – $49.00
Franklin Sports Dagger Pickleball Set – $72.00
Story continues below advertisement
Jamieson Kids Multivitamin Gummies Mixed Fruit – $28.99
Athena Club Winter Glow Set – $36.96
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
40 minutes ago
- Global News
Worried about radioactive shrimp? CFIA says no sign they were sold here
Seafood lovers in the U.S. are being warned about a recall over the risk of potentially radioactive shrimp — and no, it's not a character in a new superhero movie. The U.S. Food and Drug Administration on Tuesday issued a warning about a frozen shrimp brand sold at some Walmart stores in the U.S. due to radioactive contamination in one shipment that was identified before it entered the country. The FDA warning covers multiple lots of shrimp sold by distributors in the U.S. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy However, authorities in Canada told Global News that there were no reports of the affected product being sold in Canada. 'The Canadian Food Inspection Agency (CFIA) is aware of the public advisory published by the United States (U.S.) Food and Drug Administration (FDA) advising the U.S. public to not eat, sell, or serve certain imported shrimp. The CFIA is not aware of any Canadian distribution of these recalled products,' a CFIA spokesperson told Global News in an emailed statement. Story continues below advertisement The U.S. notice pertains to certain frozen shrimp products sold by Indonesian company PT Bahari Makmur Sejati, sold in the U.S. under the label BMS Foods. The affected product was sold at Walmart stores in 13 U.S. states — Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Pennsylvania, Texas and West Virginia. The U.S. FDA discovered high levels of Caesium-137 — a radioactive isotope — in a single shipment of the shrimp that did not enter the U.S. The notice said 'exposure to low-level radiation' from the radioactive containment can cause 'an elevated risk of cancer, resulting from damage to DNA within living cells of the body.'
The Market Online
an hour ago
- The Market Online
Ocumetics stock continues to climb after bionic lens implant
Shares of Ocumetics Technology (TSXV:OTC) are up by almost 400 per cent following Monday's announcement of a historical milestone: the first-in-human implant of a bionic intraocular lens Ocumetics is a Canadian research and product development company focused on vision-correction solutions Ocumetics stock has added 464.52 per cent year-over-year Shares of Ocumetics Technology (TSXV:OTC) are up by almost 400 per cent following Monday's announcement of a historical milestone: the first-in-human implant of a bionic intraocular lens. This content has been prepared as part of a partnership with Ocumetics Technology Corp., and is intended for informational purposes only. Unlike traditional monofocal or multifocal lenses, the Ocumetics Lens is designed to work with the natural movements of the eye, allowing the user to see clearly close up and at a distance without glasses or contacts following cataract surgery. The successful procedure is an important step in the drive to restore dynamic vision, with initial post-operative results expected in the coming weeks and additional implants planned under the clinical trial program over the coming months. Leadership insights 'This is a moment of immense pride for our team and everyone who has believed in Ocumetics from the beginning,' Dean Burns, Ocumetics Technology's president and chief executive officer, stated in Monday's news release. 'For nearly two decades, we've been focused on a bold vision, one that many thought was out of reach. Our scientists, engineers, clinical advisors and partners have poured their hearts into this innovation. Today we celebrate this success, but we know the work is far from done. There are millions of people waiting for us to get the Ocumetics Lens to market, and we are more driven than ever to bring this solution to the world.' 'The Ocumetics accommodating intraocular lens has the potential to reshape the global standard of care first for cataract, and eventually, presbyopia patients,' Burns added. 'This milestone reinforces Ocumetics' position as a leader in the next generation of ophthalmic innovation. With aging populations around the globe demanding better vision solutions, the potential impact of the Ocumetics Lens is profound.' About Ocumetics Technology Ocumetics is a Canadian research and product development company focused on vision-correction solutions, including an intraocular lens that fits within the eye's natural lens compartment. Ocumetics stock (TSXV:OTC) is up by 75 per cent trading at C$1.75 as of 10:51 am ET. The stock has added 464.52 per cent year-over-year. Join the discussion: Find out what investors are saying about this Canadian healthcare technology stock on the Ocumetics Technology Corp. Bullboard, and make sure to explore the rest of Stockhouse's stock forums and message boards. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
Global News
4 hours ago
- Global News
Canadians won't see price of weight-loss drug Mounjaro rise despite U.K. hike
People using the popular weight-loss drug Mounjaro in the United Kingdom are set to pay a higher price for it, as pharmaceutical giant Eli Lilly said it will raise the U.K. list price by up to 170 per cent. This comes as U.S. President Donald Trump is trying to get drugmakers to raise prices in Europe to allow for price cuts in the United States. However, Canadians are not going to see a price hike, a spokesperson for Eli Lilly Canada told Global News. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'Last week's announcement was specific to the UK, not Canada, so there are no pricing updates to share for Canadian patients,' the spokesperson told Global News in an emailed statement. The new U.K. price, which also applies to Lilly's Type 2 diabetes medicine with the same name, is effective from September. The price for a month's supply of the highest dose of the medicine will increase from £122 to £330 (C$227.98 to C$616.67), the company said. Story continues below advertisement The move reflects how the pharmaceutical industry is navigating policy changes in the United States, by far its most lucrative market, where Trump is pushing for lower domestic prices and encouraging price hikes overseas. Last week, Eli Lilly CEO David Ricks told an investor call that parity between U.S. and European drug pricing was desirable in the long run, though he warned that European governments 'are not signing up to pay more for drugs.' — with files from Reuters
